These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22238189)

  • 1. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
    James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
    Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
    J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic right ventricular dysplasia: a United States experience.
    Dalal D; Nasir K; Bomma C; Prakasa K; Tandri H; Piccini J; Roguin A; Tichnell C; James C; Russell SD; Judge DP; Abraham T; Spevak PJ; Bluemke DA; Calkins H
    Circulation; 2005 Dec; 112(25):3823-32. PubMed ID: 16344387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey.
    Versteeg H; Starrenburg A; Denollet J; Palen Jv; Sears SF; Pedersen SS
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):283-93. PubMed ID: 22229519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific differences in women with implantable cardioverter defibrillators: an international multi center study.
    Vazquez LD; Kuhl EA; Shea JB; Kirkness A; Lemon J; Whalley D; Conti JB; Sears SF
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1528-34. PubMed ID: 19067804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
    Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Ma KJ; Li N; Wang HT; Chu JM; Fang PH; Yao Y; Ma J; Hua W; Zhang S; Wang FZ; Li Z; Pu JL
    Chin Med J (Engl); 2009 May; 122(10):1133-8. PubMed ID: 19493458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of poor device acceptance and Type D personality is associated with increased distress in Danish cardioverter-defibrillator patients.
    Pedersen SS; Spindler H; Johansen JB; Mortensen PT
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):29-36. PubMed ID: 19140910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
    Rhodes AC; Murray B; Tichnell C; James CA; Calkins H; Sears SF
    Int J Cardiol; 2017 Dec; 248():216-220. PubMed ID: 28823501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
    Burns JL; Serber ER; Keim S; Sears SF
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.